<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03915301</url>
  </required_header>
  <id_info>
    <org_study_id>1/2019/VUSCH/EK</org_study_id>
    <nct_id>NCT03915301</nct_id>
  </id_info>
  <brief_title>Effective Postoperative Pain Treatment After Sternotomy. Comparison of the Erector Spinae Plane Block vs Conventional Opioid Treatment</brief_title>
  <acronym>VUSCH/POPT1</acronym>
  <official_title>VUSCH/PostOperativePainTreatment1</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pavol Jozef Safarik University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pavol Jozef Safarik University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparison of effect between Erector Spinae plane block and conventional opioid treatment
      after cardiac surgery
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Comparison of effect between Erector Spinae plane block and conventional opioid treatment
      after cardiac surgery. In group &quot;A&quot; will be erector spinae plane block provided in the
      thoracic part of the body, under ultrasound control. In the group B will be analgesia
      provided by Pethidine. Numerical pain score will be recorded every 2 hours, also usage of
      analgetics will be recorded in both groups.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">July 20, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>4 Months</target_duration>
  <primary_outcome>
    <measure>Satisfaction with pain treatment assessed by the numerical rating scale VAS</measure>
    <time_frame>12 hours</time_frame>
    <description>Pain assessed by VAS 0-10 score</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Pain Reliefe</condition>
  <arm_group>
    <arm_group_label>ESPB</arm_group_label>
    <description>Erector spinae plane block group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Opioids</arm_group_label>
    <description>Opioid group</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Satisfaction assessed by the VAS [followed by its scale information in the Description]</intervention_name>
    <description>Erector spinae plane block provided in thoracic part of spine, VAS scale 0-10</description>
    <arm_group_label>ESPB</arm_group_label>
    <arm_group_label>Opioids</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients after cardiac surgery
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Postoperative state after cardiac surgery, Serious pain NRS 8-10

        Exclusion Criteria:

          -  disagreement
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Ladislav Kočan, MD, PhD</last_name>
    <phone>00421907440250</phone>
    <email>lkocan@vusch.sk</email>
  </overall_contact>
  <location>
    <facility>
      <name>East Slovak Institute for Cardiovascular Diseases</name>
      <address>
        <city>Kosice</city>
        <zip>04011</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ladislav Kocan, MD PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Slovakia</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>April 8, 2019</study_first_submitted>
  <study_first_submitted_qc>April 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 16, 2019</study_first_posted>
  <last_update_submitted>July 2, 2019</last_update_submitted>
  <last_update_submitted_qc>July 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pavol Jozef Safarik University</investigator_affiliation>
    <investigator_full_name>Kočan Ladislav</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

